Home Industry Reports Custom Research Blogs About Us Contact us

Anthelmintic Drugs Market Size

Report ID: FBI 3555

|

Published Date: May-2024

|

Format : PDF, Excel

Market Outlook:

Anthelmintic Drugs Market size was over USD 2.52 Billion in 2023 and is predicted to surpass USD 3.56 Billion by end of the year 2032, observing around 3.9% CAGR between 2024 and 2032.

Base Year Value (2023)

USD 2.52 Billion

19-23 x.x %
24-32 x.x %

CAGR (2024-2032)

3.9%

19-23 x.x %
24-32 x.x %

Forecast Year Value (2032)

USD 3.56 Billion

19-23 x.x %
24-32 x.x %
Anthelmintic Drugs Market

Historical Data Period

2019-2023

Anthelmintic Drugs Market

Largest Region

Asia Pacific

Anthelmintic Drugs Market

Forecast Period

2024-2032

Get more details on this report -

Market Dynamics:

Growth Drivers & Opportunity:

1. Increasing prevalence of parasitic infections: One of the major growth drivers for the anthelmintic drugs market is the rising prevalence of parasitic infections, particularly in developing countries. Parasitic infections such as soil-transmitted helminths, schistosomiasis, and filariasis are widespread in many regions, driving the demand for anthelmintic drugs.

2. Technological advancements in drug development: The development of advanced technologies such as high throughput screening and molecular modeling has led to the discovery of novel anthelmintic drugs with improved efficacy and safety profiles. This has created significant growth opportunities for pharmaceutical companies operating in the anthelmintic drugs market.

3. Increasing investment in research and development: Growing investment in research and development activities focused on the development of new and more effective anthelmintic drugs is driving market growth. This includes government initiatives, private funding, and collaborations between academic institutions and pharmaceutical companies to advance drug discovery and development in the field of anthelmintics.

4. Expansion of veterinary anthelmintic drugs market: The increasing demand for anthelmintic drugs in veterinary medicine, particularly in the livestock and companion animal sectors, is a significant growth driver for the overall anthelmintic drugs market. The expanding pet ownership and rising concerns related to parasitic infections in animals are driving the demand for anthelmintic drugs in the veterinary segment.

Industry

Report Scope

Report CoverageDetails
Segments CoveredType, Application, Distribution Channel
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledNovartis International AG, Elanco Animal Health, Virbac, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Norbrook Laboratories Limited, Agrimin Limited, Merial Animal Health Limited, Jurox Pty Limited among others.

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

1. Drug resistance: One of the major restraints for the anthelmintic drugs market is the development of drug-resistant parasitic strains. Prolonged and widespread use of anthelmintic drugs has led to the emergence of resistance in parasites, reducing the efficacy of existing drugs and necessitating the development of new treatment options.

2. Stringent regulatory requirements: The stringent regulatory requirements for the approval of anthelmintic drugs, particularly in developed countries, pose a challenge for market players. The complex and time-consuming regulatory pathways for drug approval can significantly delay the launch of new anthelmintic drugs and increase the overall cost of drug development.

3. Limited access to healthcare in developing countries: Limited access to healthcare facilities and lack of awareness about parasitic infections in many developing regions can act as a restraint for the anthelmintic drugs market. This hinders the proper diagnosis and treatment of parasitic infections, thereby limiting the market potential for anthelmintic drugs in these regions.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Anthelmintic Drugs Market Size & Share, By Type, A...

RD Code : 24